Viewsroom
Breakingviews columnists talk about the big numbers, crunchy deals and nasty spats in global business and economics, offering a weekly dose of financial insight that goes beyond the concise and provocative views readers get from our columns every day.

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(512)

Man United sale heads into messy added time

Man United sale heads into messy added time

The Premier League soccer club is in the final stages of a tense bidding war. In this Viewsroom podcast, Breakingviews columnists debate the merits of offers from a Qatari suitor and chemicals tycoon ...

15 Jun 202311min

Saudi oil cuts collide with investor scepticism

Saudi oil cuts collide with investor scepticism

The Gulf state is slashing oil production in July and convinced OPEC+ to extend cuts to the end of 2024. In this Viewsroom podcast, Breakingviews columnists explain how these restrictions may still no...

8 Jun 202318min

Syngenta’s bumper IPO will test Chinese appetite

Syngenta’s bumper IPO will test Chinese appetite

The seeds-to-pesticides group is planning a $9 bln stock market float in Shanghai this year. In this Viewsroom podcast, Breakingviews columnists explain how investors need to get comfortable with its ...

1 Jun 202317min

Debt ceiling crash will have few victims

Debt ceiling crash will have few victims

President Joe Biden is trying to hammer out a deal with Republican lawmakers to ensure the United States can keep its lights on. In this Viewsroom podcast, Breakingviews columnists explain how even if...

25 Mai 202313min

Erdogan part three would be worse and the same

Erdogan part three would be worse and the same

The Turkish president is in a heated battle to lead the battered country. In this Viewsroom podcast, Breakingviews columnists discuss the risks Turkey faces if he stays in office, his rival’s offering...

18 Mai 202311min

Pharma’s obesity gold rush will have limits

Pharma’s obesity gold rush will have limits

Drugmakers Novo Nordisk and Eli Lilly are vying for a large slab of the weight loss medications market, which analysts reckon could be worth $100 bln by 2031. In this Viewsroom podcast, Breakingviews ...

11 Mai 202314min

First Republic’s rescue cements ‘too big to fail’

First Republic’s rescue cements ‘too big to fail’

JPMorgan rode to the rescue of the mid-sized lender, which recently became the latest US bank to keel over. In this Viewsroom podcast, Breakingviews columnists discuss the impact of lending giants bul...

4 Mai 202311min

EY’s failed split raises stakes for Plan B

EY’s failed split raises stakes for Plan B

The Big Four professional services firm called off a plan to separate its audit and consulting arms. In this Viewsroom podcast, Breakingviews columnists discuss what went wrong, the implications for i...

27 Apr 202314min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
forklart
aftenpodden-usa
popradet
stopp-verden
nokon-ma-ga
dine-penger-pengeradet
lydartikler-fra-aftenposten
det-store-bildet
rss-espen-lee-usensurert
hanna-de-heldige
rss-gukild-johaug
rss-ness
aftenbla-bla
e24-podden
frokostshowet-pa-p5
rss-penger-polser-og-politikk
grasoner-den-nye-kalde-krigen
rss-borsmorgen-okonominyhetene